China plus one is too thin as a board phrase. Global brands need a six-exposure counter-map covering demand, sourcing, technology, competitors, policy, and market sequencing. India should be tested only where it credibly reduces, redirects, or rebalances specific exposure.
“China plus one” sounds decisive.
It often hides the real question.
Where exactly is the company exposed to China?
Demand? Sourcing? Technology? Competitors? Policy? Market sequencing?
Until those exposures are mapped, diversification is a slogan.
Board Signal: China is no longer a single-line risk in the board pack. It is a market, supplier, competitor base, technology ecosystem, policy actor, and leverage system. Mapping China exposure does not mean exiting China. It means knowing where China sits in the company’s operating model before deciding whether India can address a specific exposure.
The six-exposure counter-map
A serious board discussion should map China across six exposures.
This is the ROSS Exposure Map applied specifically to China. It is not a separate framework from the master note; it is the same lens used at a more precise level.
1. Demand exposure
How much growth, margin, or investor confidence depends on Chinese consumer demand?
If the category becomes more local, more promotional, or more difficult for foreign brands, what happens to the growth story?
2. Sourcing exposure
Which finished goods, components, raw materials, packaging, machines, moulds, tooling, electronics, or sub-assemblies depend on China?
Which alternatives are commercially real?
Which alternatives exist only in strategy decks?
3. Technology exposure
Where does the company depend on China-linked hardware, manufacturing equipment, batteries, sensors, retail technology, payment devices, logistics systems, energy systems, or digital infrastructure?
A fashion, F&B, beauty, footwear, or lifestyle brand may not buy semiconductors directly. But it depends on POS systems, warehouse automation, payments, consumer devices, logistics infrastructure, digital advertising systems, and increasingly AI-enabled planning. The technology stack underneath retail is no longer neutral to geopolitics.
For example, a premium beauty, fashion, or F&B brand may appear consumer-facing, but its India or Gulf rollout can still depend on Chinese-origin devices, store hardware, refrigeration components, warehouse systems, payment terminals, lighting, displays, or logistics technology. The exposure may sit below the brand layer, but it can still affect launch timing, maintenance, cost, and resilience.
4. Competitor exposure
Which Chinese competitors are expanding into the company’s categories or target markets?
Are they stronger on price, speed, digital execution, channel aggression, supply control, or product iteration?
5. Policy exposure
Could export controls, sanctions, procurement rules, industrial policy, legal retaliation, or national-security restrictions affect supply, data, technology, or market access?
6. Market-sequencing exposure
If China becomes harder and the West becomes slower, which markets deserve earlier testing?
This is where India belongs.
China is building leverage into the operating system
Recent reporting indicates that China has expanded its economic countermeasure toolkit during its trade truce with the US, including restrictions around heavy rare earths, lithium-ion battery components, advanced solar equipment, semiconductor localisation, AI chips in state-funded data centres, and legal tools against extraterritorial pressure or discriminatory supply-chain measures.
That list may sound industrial rather than consumer-facing.
It is not remote from consumer brands.
Modern retail depends on technology, energy, logistics, sensors, payments, automation, digital marketing, and connected supply chains. Consumer brands increasingly sit on top of industrial and technological systems they do not fully see.
When a leverage point moves, the visible effect may appear much later as cost, delay, shortage, compliance friction, channel pressure, or competitor advantage.
China is also becoming an external competitor problem
The China question is no longer restricted to China market performance.
Chinese brands are going outward.
McKinsey’s 2026 global trade update notes that tariffs triggered trade readjustment, with US-China trade falling by around 30%, while Chinese exporters of consumer goods cut prices by an average of 8% to find buyers in new markets.
That is a board signal.
If Chinese brands face more pressure at home or in traditional export channels, they will not simply retreat. They will redirect. They will enter adjacent markets. They will compete more aggressively in Southeast Asia, the Gulf, Europe, Latin America, Africa, and India.
A global brand therefore needs to ask:
Where could Chinese competition affect us outside China?
In which markets are we assuming premium defensibility that may not hold?
Which categories are exposed to faster, cheaper, better-localized Chinese alternatives?
India enters as a specific counter-map position
India should not be inserted into this note as a slogan.
It should be assessed position by position.
India may be relevant as:
- a demand market,
- a sourcing base,
- an assembly location,
- a digital consumer market,
- a portfolio hedge,
- a category test market,
- or a regionally independent growth platform.
Each role has different implications.
An India sales-market decision is not the same as an India sourcing decision.
An India assembly decision is not the same as an India channel-entry decision.
An India hedge decision is not the same as an India scale decision.
That distinction matters because bad India entry often begins when boards use one word, “India,” to cover several completely different business models.
What India can and cannot do
India can offer demographic depth, domestic demand, digital adoption, premium-consumption pockets, policy relevance, and category-specific sourcing potential. It can also offer a separate consumer-growth platform for brands that are overdependent on China demand or underprepared for Chinese competitors expanding abroad.
India cannot instantly replicate China’s manufacturing density, supplier depth, export infrastructure, or industrial speed across all sectors. It also adds its own duties, standards, state-level variation, channel complexity, and execution demands.
That is not a weakness in the argument. It is the discipline required by the argument.
India has to be tested precisely.
Where does it genuinely reduce China exposure?
Where does it create new exposure?
Where does it improve resilience?
Where does it add cost or complexity?
Where does it deserve a live capital discussion?
The board questions
The board should ask:
- How much growth is still assumed from China demand?
- Which supply-chain elements remain China-dependent?
- Which technology dependencies sit below the visible consumer business?
- Which Chinese competitors are moving into our markets?
- Which policy actions could affect our category?
- Which India role is actually being discussed: sales, sourcing, assembly, hedge, or scale?
These six questions are the counter-map.
Closing argument
The China question is no longer “Should we reduce China?”
That question is too crude.
The board question is where China sits inside the company’s demand, sourcing, technology, competitor, policy, and sequencing exposure.
Only then can India be tested intelligently.
India may reduce one exposure and create another. It may be right for one category and wrong for another. It may work as a sales market before it works as a sourcing base. It may require a different capital posture from the one imagined at headquarters.
That is the discipline beyond China plus one.
ROSS view
ROSS uses this note as a board question: Where exactly is the company exposed to China, and where can India credibly reduce or rebalance that exposure?